Locate Therapeutics Gets £2m Injection
Regenerative medicine company, Locate Therapeutics, has raised £2m ($2.6m) to advance development of its injectable matrix platform, capable of providing mechanical support for tissue repair whilst also delivering targeted drug and stem cell therapy.
You may also be interested in...
Smith & Nephew has acquired Tusker Medical for an undisclosed price. The acquisition comes just months after Tusker’s Tula system was approved by the FDA as a breakthrough device.
One year on from its IPO on Euronext Brussels, abdominal implant maker Sequana Medical has secured €19m ($21m) in an equity placement. The company said it had been backed by new and existing investors.
Quanta Dialysis has signed an agreement with B. Braun to provide support services to Quanta’s patients in the UK. The hemodialysis firm launched its compact hemodialysis device SC+ on the market at the beginning of the year.